Pharma & Healthcare
Global Argatroban Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2025-2031
- Jun 01, 25
- ID: 285743
- Pages: 123
- Figures: 137
- Views: 30
In 2024, the global market size of Argatroban was estimated to be worth US$ 56.2 million and is forecast to reach approximately US$ 37.8 million by 2031 with a CAGR of -5.6% during the forecast period 2025-2031.
Argatroban is a synthetic direct thrombin inhibitor and the chemical name is 1-[5- [(aminoiminomethyl)amino]-1-oxo-2-[[(1,2,3,4-tetrahydro-3-methyl-8-quinolinyl)sulfonyl]amino]pentyl]-4-methyl-2-piperidinecarboxylic acid, monohydrate. Argatroban has 4 asymmetric carbons. One of the asymmetric carbons has an R configuration (stereoisomer Type I) and an S configuration (stereoisomer Type II). Argatroban consists of a mixture of R and S stereoisomers at a ratio of approximately 65:35.
Global Argatroban key players include Mitsubishi Tanabe Pharma, Pfizer, Inc, Teva Pharmaceutical Industries Ltd, SANDOZ, etc. Global top four manufacturers hold a share nearly 60%.
Japan is the largest market, with a share about 35%, followed by Europe, and USA, both have a share about 55 percent.
In terms of product, Argatroban Injection is the largest segment, with a share over 70%. And in terms of application, the largest application is Heparin-induced thrombocytopenia (HIT), followed by Percutaneous Coronary Intervention, Cerebral arterial thrombosis.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Argatroban, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Argatroban.
The Argatroban market size, estimations, and forecasts are provided in terms of sales volume (g) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Argatroban market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Argatroban manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and regions.
By Company
Pfizer, Inc
SANDOZ
GlaxoSmithKline Plc
fresenius-kabi
Eagle Pharmaceuticals, Inc
Mitsubishi Tanabe Pharma
Teva Pharmaceutical Industries Ltd
WEST-WARD,INC
Segment by Type
Argatroban Powder
Argatroban Injection
Segment by Application
Heparin-induced Thrombocytopenia (HIT)
Percutaneous Coronary Intervention
Cerebral Arterial Thrombosis
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
India
Southeast Asia
Australia
Rest of Asia-Pacific
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type and by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Sales (consumption), revenue of Argatroban in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 3: Detailed analysis of Argatroban manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Argatroban sales, revenue, price, gross margin, sales by region, by Type, by Application, and recent development, etc.
Chapter 5: Provides the analysis of various market segments by Type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 6: Provides the analysis of various market segments by Application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 7: North America by Type, by Application and by country, sales, and revenue for each segment.
Chapter 8: APAC by Type, by Application and by country, sales, and revenue for each segment.
Chapter 9: Europe by Type, by Application and by country, sales, and revenue for each segment.
Chapter 10: Latin America by Type, by Application and by country, sales, and revenue for each segment.
Chapter 11: Middle East and Africa by Type, by Application and by country, sales, and revenue for each segment.
Chapter 12: Analysis of industrial chain, sales channel, key raw materials, distributors, and customers.
Chapter 13: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 14: Research Findings and Conclusion.
Argatroban is a synthetic direct thrombin inhibitor and the chemical name is 1-[5- [(aminoiminomethyl)amino]-1-oxo-2-[[(1,2,3,4-tetrahydro-3-methyl-8-quinolinyl)sulfonyl]amino]pentyl]-4-methyl-2-piperidinecarboxylic acid, monohydrate. Argatroban has 4 asymmetric carbons. One of the asymmetric carbons has an R configuration (stereoisomer Type I) and an S configuration (stereoisomer Type II). Argatroban consists of a mixture of R and S stereoisomers at a ratio of approximately 65:35.
Global Argatroban key players include Mitsubishi Tanabe Pharma, Pfizer, Inc, Teva Pharmaceutical Industries Ltd, SANDOZ, etc. Global top four manufacturers hold a share nearly 60%.
Japan is the largest market, with a share about 35%, followed by Europe, and USA, both have a share about 55 percent.
In terms of product, Argatroban Injection is the largest segment, with a share over 70%. And in terms of application, the largest application is Heparin-induced thrombocytopenia (HIT), followed by Percutaneous Coronary Intervention, Cerebral arterial thrombosis.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Argatroban, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Argatroban.
The Argatroban market size, estimations, and forecasts are provided in terms of sales volume (g) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Argatroban market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Argatroban manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and regions.
By Company
Pfizer, Inc
SANDOZ
GlaxoSmithKline Plc
fresenius-kabi
Eagle Pharmaceuticals, Inc
Mitsubishi Tanabe Pharma
Teva Pharmaceutical Industries Ltd
WEST-WARD,INC
Segment by Type
Argatroban Powder
Argatroban Injection
Segment by Application
Heparin-induced Thrombocytopenia (HIT)
Percutaneous Coronary Intervention
Cerebral Arterial Thrombosis
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
India
Southeast Asia
Australia
Rest of Asia-Pacific
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type and by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Sales (consumption), revenue of Argatroban in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 3: Detailed analysis of Argatroban manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Argatroban sales, revenue, price, gross margin, sales by region, by Type, by Application, and recent development, etc.
Chapter 5: Provides the analysis of various market segments by Type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 6: Provides the analysis of various market segments by Application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 7: North America by Type, by Application and by country, sales, and revenue for each segment.
Chapter 8: APAC by Type, by Application and by country, sales, and revenue for each segment.
Chapter 9: Europe by Type, by Application and by country, sales, and revenue for each segment.
Chapter 10: Latin America by Type, by Application and by country, sales, and revenue for each segment.
Chapter 11: Middle East and Africa by Type, by Application and by country, sales, and revenue for each segment.
Chapter 12: Analysis of industrial chain, sales channel, key raw materials, distributors, and customers.
Chapter 13: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 14: Research Findings and Conclusion.
1 Study Coverage
1.1 Argatroban Product Introduction
1.2 Market by Type
1.2.1 Global Argatroban Market Size Growth Rate by Type (2020 VS 2024 VS 2031)
1.2.2 Argatroban Powder
1.2.3 Argatroban Injection
1.3 Market by Application
1.3.1 Global Argatroban Market Size Growth Rate by Application (2020 VS 2024 VS 2031)
1.3.2 Heparin-induced Thrombocytopenia (HIT)
1.3.3 Percutaneous Coronary Intervention
1.3.4 Cerebral Arterial Thrombosis
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Argatroban Market Size Estimates and Forecasts
2.1.1 Global Argatroban Revenue 2020-2031
2.1.2 Global Argatroban Sales 2020-2031
2.2 Argatroban Market Size by Region: 2024 Versus 2031
2.3 Argatroban Sales by Region (2020-2031)
2.3.1 Global Argatroban Sales by Region: 2020-2025
2.3.2 Global Argatroban Sales Forecast by Region (2026-2031)
2.3.3 Global Argatroban Sales Market Share by Region (2020-2031)
2.4 Argatroban Market Estimates and Projections by Region (2026-2031)
2.4.1 Global Argatroban Revenue by Region: 2020-2025
2.4.2 Global Argatroban Revenue Forecast by Region (2026-2031)
2.4.3 Global Argatroban Revenue Market Share by Region (2020-2031)
3 Market Segments
3.1 Breakdown Data by Type
3.1.1 Global Argatroban Sales by Type (2020-2031)
3.1.1.1 Global Argatroban Sales Volume by Type (2020-2031)
3.1.1.2 Global Argatroban Sales Market Share by Type (2020-2031)
3.1.2 Global Argatroban Revenue by Type (2020-2031)
3.1.2.1 Global Argatroban Revenue by Type (2020-2031)
3.1.2.2 Global Argatroban Revenue Market Share by Type (2020-2031)
3.1.3 Argatroban Average Selling Price (ASP) by Type (2020-2031)
3.2 Breakdown Data by Application
3.2.1 Global Argatroban Sales by Application (2020-2031)
3.2.1.1 Global Argatroban Sales Volume by Application (2020-2031)
3.2.1.2 Global Argatroban Sales Market Share by Application (2020-2031)
3.2.2 Global Argatroban Revenue by Application (2020-2031)
3.2.2.1 Global Argatroban Revenue by Application (2020-2031)
3.2.2.2 Global Argatroban Revenue Market Share by Application (2020-2031)
3.2.3 Argatroban Average Selling Price (ASP) by Application (2020-2031)
3.3 by Type and by Application Crossing Analysis
3.3.1 Argatroban Powder of Argatroban Revenue Market Share by Application
3.3.2 Argatroban Injection of Argatroban Revenue Market Share by Application
4 Global Argatroban by Manufacturers
4.1 Global Top Argatroban Manufacturers by Sales (2020-2025)
4.1.1 Global Argatroban Sales by Manufacturer (2020-2025)
4.1.2 Global Argatroban Sales Market Share by Manufacturer (2020-2025)
4.2 Global Top Argatroban Manufacturers by Revenue (2020-2025)
4.2.1 Global Argatroban Revenue by Manufacturer (2020-2025)
4.2.2 Global Argatroban Revenue Share by Manufacturer (2020-2025)
4.3 Global Argatroban Price by Manufacturer (2020-2025)
4.4 Competitive Landscape
4.4.1 Key Argatroban Manufacturers Covered: Ranking by Revenue
4.4.2 Global Argatroban Market Concentration Ratio (CR5 and HHI) & (2020-2025)
4.4.3 Global Argatroban Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
4.5 Global Argatroban Manufacturing Base Distribution, Product Type
4.5.1 Argatroban Manufacturers Manufacturing Base Distribution, Headquarters
4.5.2 Date of International Manufacturers Enter into Argatroban Market
4.5.3 Manufacturers Argatroban Product Type and Application
4.5.4 Argatroban Powder Market Sales of Argatroban by Manufacturer
4.5.5 Argatroban Injection Market Sales of Argatroban by Manufacturer
4.6 Manufacturers Mergers & Acquisitions, Expansion Plans
5 Company Profiles
5.1 Pfizer, Inc
5.1.1 Pfizer, Inc Company Information
5.1.2 Pfizer, Inc Description, Business Overview
5.1.3 Pfizer, Inc Argatroban Products Offered
5.1.4 Pfizer, Inc Argatroban Sales, Revenue and Gross Margin (2020-2025)
5.1.5 Pfizer, Inc Argatroban Sales by Product in 2024
5.1.6 Pfizer, Inc Argatroban Sales by Application in 2024
5.1.7 Pfizer, Inc Argatroban Sales by Geographic Area in 2024
5.1.8 Pfizer, Inc Recent Developments
5.2 SANDOZ
5.2.1 SANDOZ Company Information
5.2.2 SANDOZ Description, Business Overview
5.2.3 SANDOZ Argatroban Products Offered
5.2.4 SANDOZ Argatroban Sales, Revenue and Gross Margin (2020-2025)
5.2.5 SANDOZ Argatroban Sales by Product in 2024
5.2.6 SANDOZ Argatroban Sales by Application in 2024
5.2.7 SANDOZ Argatroban Sales by Geographic Area in 2024
5.2.8 SANDOZ Recent Developments
5.3 GlaxoSmithKline Plc
5.3.1 GlaxoSmithKline Plc Company Information
5.3.2 GlaxoSmithKline Plc Description, Business Overview
5.3.3 GlaxoSmithKline Plc Argatroban Products Offered
5.3.4 GlaxoSmithKline Plc Argatroban Sales, Revenue and Gross Margin (2020-2025)
5.3.5 GlaxoSmithKline Plc Argatroban Sales by Product in 2024
5.3.6 GlaxoSmithKline Plc Argatroban Sales by Application in 2024
5.3.7 GlaxoSmithKline Plc Argatroban Sales by Geographic Area in 2024
5.3.8 GlaxoSmithKline Plc Recent Developments
5.4 fresenius-kabi
5.4.1 fresenius-kabi Company Information
5.4.2 fresenius-kabi Description, Business Overview
5.4.3 fresenius-kabi Argatroban Products Offered
5.4.4 fresenius-kabi Argatroban Sales, Revenue and Gross Margin (2020-2025)
5.4.5 fresenius-kabi Argatroban Sales by Product in 2024
5.4.6 fresenius-kabi Argatroban Sales by Application in 2024
5.4.7 fresenius-kabi Argatroban Sales by Geographic Area in 2024
5.4.8 fresenius-kabi Recent Developments
5.5 Eagle Pharmaceuticals, Inc
5.5.1 Eagle Pharmaceuticals, Inc Company Information
5.5.2 Eagle Pharmaceuticals, Inc Description, Business Overview
5.5.3 Eagle Pharmaceuticals, Inc Argatroban Products Offered
5.5.4 Eagle Pharmaceuticals, Inc Argatroban Sales, Revenue and Gross Margin (2020-2025)
5.5.5 Eagle Pharmaceuticals, Inc Argatroban Sales by Product in 2024
5.5.6 Eagle Pharmaceuticals, Inc Argatroban Sales by Application in 2024
5.5.7 Eagle Pharmaceuticals, Inc Argatroban Sales by Geographic Area in 2024
5.5.8 Eagle Pharmaceuticals, Inc Recent Developments
5.6 Mitsubishi Tanabe Pharma
5.6.1 Mitsubishi Tanabe Pharma Company Information
5.6.2 Mitsubishi Tanabe Pharma Description, Business Overview
5.6.3 Mitsubishi Tanabe Pharma Argatroban Products Offered
5.6.4 Mitsubishi Tanabe Pharma Argatroban Sales, Revenue and Gross Margin (2020-2025)
5.6.5 Mitsubishi Tanabe Pharma Argatroban Sales by Product in 2024
5.6.6 Mitsubishi Tanabe Pharma Argatroban Sales by Application in 2024
5.6.7 Mitsubishi Tanabe Pharma Argatroban Sales by Geographic Area in 2024
5.6.8 Mitsubishi Tanabe Pharma Recent Developments
5.7 Teva Pharmaceutical Industries Ltd
5.7.1 Teva Pharmaceutical Industries Ltd Company Information
5.7.2 Teva Pharmaceutical Industries Ltd Description, Business Overview
5.7.3 Teva Pharmaceutical Industries Ltd Argatroban Products Offered
5.7.4 Teva Pharmaceutical Industries Ltd Argatroban Sales, Revenue and Gross Margin (2020-2025)
5.7.5 Teva Pharmaceutical Industries Ltd Argatroban Sales by Product in 2024
5.7.6 Teva Pharmaceutical Industries Ltd Argatroban Sales by Application in 2024
5.7.7 Teva Pharmaceutical Industries Ltd Argatroban Sales by Geographic Area in 2024
5.7.8 Teva Pharmaceutical Industries Ltd Recent Developments
5.8 WEST-WARD,INC
5.8.1 WEST-WARD,INC Company Information
5.8.2 WEST-WARD,INC Description, Business Overview
5.8.3 WEST-WARD,INC Argatroban Products Offered
5.8.4 WEST-WARD,INC Argatroban Sales, Revenue and Gross Margin (2020-2025)
5.8.5 WEST-WARD,INC Argatroban Sales by Product in 2024
5.8.6 WEST-WARD,INC Argatroban Sales by Application in 2024
5.8.7 WEST-WARD,INC Argatroban Sales by Geographic Area in 2024
5.8.8 WEST-WARD,INC Recent Developments
6 North America
6.1 North America Argatroban Market Size YoY Growth 2020-2031
6.2 North America Argatroban Market Facts & Figures by Country
6.2.1 North America Argatroban Sales by Country (2020-2031)
6.2.2 North America Argatroban Revenue by Country (2020-2031)
6.3 North America Argatroban Sales by Type (2020-2025)
6.4 North America Argatroban Sales by Application (2020-2025)
7 Asia-Pacific
7.1 Asia-Pacific Argatroban Market Size YoY Growth 2020-2031
7.2 Asia-Pacific Argatroban Market Facts & Figures by Region
7.2.1 Asia-Pacific Argatroban Sales by Region (2020-2031)
7.2.2 Asia-Pacific Argatroban Revenue by Region (2020-2031)
7.3 Asia-Pacific Argatroban Sales by Type (2020-2025)
7.4 Asia-Pacific Argatroban Sales by Application (2020-2025)
8 Europe
8.1 Europe Argatroban Market Size YoY Growth 2020-2031
8.2 Europe Argatroban Market Facts & Figures by Country
8.2.1 Europe Argatroban Sales by Country (2020-2031)
8.2.2 Europe Argatroban Revenue by Country (2020-2031)
8.3 Europe Argatroban Sales by Type (2020-2025)
8.4 Europe Argatroban Sales by Application (2020-2025)
9 Latin America
9.1 Latin America Argatroban Market Size YoY Growth 2020-2031
9.2 Latin America Argatroban Market Facts & Figures by Country
9.2.1 Latin America Argatroban Sales by Country (2020-2031)
9.2.2 Latin America Argatroban Revenue by Country (2020-2031)
9.3 Latin America Argatroban Sales by Type (2020-2025)
9.4 Latin America Argatroban Sales by Application (2020-2025)
10 Middle East and Africa
10.1 Latin America Argatroban Market Size YoY Growth 2020-2031
10.2 Middle East and Africa Argatroban Market Facts & Figures by Country
10.2.1 Middle East and Africa Argatroban Sales by Country (2020-2031)
10.2.2 Middle East and Africa Argatroban Revenue by Country (2020-2031)
10.3 Middle East and Africa Argatroban Sales by Type (2020-2025)
10.4 Middle East and Africa Argatroban Sales by Application (2020-2025)
11 Supply Chain and Sales Channel analysis
11.1 Argatroban Supply Chain Analysis
11.2 Argatroban Key Raw Materials and Upstream Suppliers
11.3 Argatroban Clients Analysis
11.4 Argatroban Sales Channel and Sales Model Analysis
11.4.1 Argatroban Distribution Channel Analysis: Indirect Sales VS Direct Sales
11.4.2 Argatroban Distribution Channel Analysis: Online Sales VS Offline Sales
11.4.3 Argatroban Distributors
12 Argatroban Market Dynamics
12.1 Argatroban Industry Trends
12.2 Argatroban Market Drivers
12.3 Argatroban Market Challenges
12.4 Argatroban Market Restraints
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.1.1 Research Programs/Design
14.1.1.2 Market Size Estimation
14.1.1.3 Market Breakdown and Data Triangulation
14.1.2 Data Source
14.1.2.1 Secondary Sources
14.1.2.2 Primary Sources
14.2 Author Details
14.3 Disclaimer
1.1 Argatroban Product Introduction
1.2 Market by Type
1.2.1 Global Argatroban Market Size Growth Rate by Type (2020 VS 2024 VS 2031)
1.2.2 Argatroban Powder
1.2.3 Argatroban Injection
1.3 Market by Application
1.3.1 Global Argatroban Market Size Growth Rate by Application (2020 VS 2024 VS 2031)
1.3.2 Heparin-induced Thrombocytopenia (HIT)
1.3.3 Percutaneous Coronary Intervention
1.3.4 Cerebral Arterial Thrombosis
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Argatroban Market Size Estimates and Forecasts
2.1.1 Global Argatroban Revenue 2020-2031
2.1.2 Global Argatroban Sales 2020-2031
2.2 Argatroban Market Size by Region: 2024 Versus 2031
2.3 Argatroban Sales by Region (2020-2031)
2.3.1 Global Argatroban Sales by Region: 2020-2025
2.3.2 Global Argatroban Sales Forecast by Region (2026-2031)
2.3.3 Global Argatroban Sales Market Share by Region (2020-2031)
2.4 Argatroban Market Estimates and Projections by Region (2026-2031)
2.4.1 Global Argatroban Revenue by Region: 2020-2025
2.4.2 Global Argatroban Revenue Forecast by Region (2026-2031)
2.4.3 Global Argatroban Revenue Market Share by Region (2020-2031)
3 Market Segments
3.1 Breakdown Data by Type
3.1.1 Global Argatroban Sales by Type (2020-2031)
3.1.1.1 Global Argatroban Sales Volume by Type (2020-2031)
3.1.1.2 Global Argatroban Sales Market Share by Type (2020-2031)
3.1.2 Global Argatroban Revenue by Type (2020-2031)
3.1.2.1 Global Argatroban Revenue by Type (2020-2031)
3.1.2.2 Global Argatroban Revenue Market Share by Type (2020-2031)
3.1.3 Argatroban Average Selling Price (ASP) by Type (2020-2031)
3.2 Breakdown Data by Application
3.2.1 Global Argatroban Sales by Application (2020-2031)
3.2.1.1 Global Argatroban Sales Volume by Application (2020-2031)
3.2.1.2 Global Argatroban Sales Market Share by Application (2020-2031)
3.2.2 Global Argatroban Revenue by Application (2020-2031)
3.2.2.1 Global Argatroban Revenue by Application (2020-2031)
3.2.2.2 Global Argatroban Revenue Market Share by Application (2020-2031)
3.2.3 Argatroban Average Selling Price (ASP) by Application (2020-2031)
3.3 by Type and by Application Crossing Analysis
3.3.1 Argatroban Powder of Argatroban Revenue Market Share by Application
3.3.2 Argatroban Injection of Argatroban Revenue Market Share by Application
4 Global Argatroban by Manufacturers
4.1 Global Top Argatroban Manufacturers by Sales (2020-2025)
4.1.1 Global Argatroban Sales by Manufacturer (2020-2025)
4.1.2 Global Argatroban Sales Market Share by Manufacturer (2020-2025)
4.2 Global Top Argatroban Manufacturers by Revenue (2020-2025)
4.2.1 Global Argatroban Revenue by Manufacturer (2020-2025)
4.2.2 Global Argatroban Revenue Share by Manufacturer (2020-2025)
4.3 Global Argatroban Price by Manufacturer (2020-2025)
4.4 Competitive Landscape
4.4.1 Key Argatroban Manufacturers Covered: Ranking by Revenue
4.4.2 Global Argatroban Market Concentration Ratio (CR5 and HHI) & (2020-2025)
4.4.3 Global Argatroban Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
4.5 Global Argatroban Manufacturing Base Distribution, Product Type
4.5.1 Argatroban Manufacturers Manufacturing Base Distribution, Headquarters
4.5.2 Date of International Manufacturers Enter into Argatroban Market
4.5.3 Manufacturers Argatroban Product Type and Application
4.5.4 Argatroban Powder Market Sales of Argatroban by Manufacturer
4.5.5 Argatroban Injection Market Sales of Argatroban by Manufacturer
4.6 Manufacturers Mergers & Acquisitions, Expansion Plans
5 Company Profiles
5.1 Pfizer, Inc
5.1.1 Pfizer, Inc Company Information
5.1.2 Pfizer, Inc Description, Business Overview
5.1.3 Pfizer, Inc Argatroban Products Offered
5.1.4 Pfizer, Inc Argatroban Sales, Revenue and Gross Margin (2020-2025)
5.1.5 Pfizer, Inc Argatroban Sales by Product in 2024
5.1.6 Pfizer, Inc Argatroban Sales by Application in 2024
5.1.7 Pfizer, Inc Argatroban Sales by Geographic Area in 2024
5.1.8 Pfizer, Inc Recent Developments
5.2 SANDOZ
5.2.1 SANDOZ Company Information
5.2.2 SANDOZ Description, Business Overview
5.2.3 SANDOZ Argatroban Products Offered
5.2.4 SANDOZ Argatroban Sales, Revenue and Gross Margin (2020-2025)
5.2.5 SANDOZ Argatroban Sales by Product in 2024
5.2.6 SANDOZ Argatroban Sales by Application in 2024
5.2.7 SANDOZ Argatroban Sales by Geographic Area in 2024
5.2.8 SANDOZ Recent Developments
5.3 GlaxoSmithKline Plc
5.3.1 GlaxoSmithKline Plc Company Information
5.3.2 GlaxoSmithKline Plc Description, Business Overview
5.3.3 GlaxoSmithKline Plc Argatroban Products Offered
5.3.4 GlaxoSmithKline Plc Argatroban Sales, Revenue and Gross Margin (2020-2025)
5.3.5 GlaxoSmithKline Plc Argatroban Sales by Product in 2024
5.3.6 GlaxoSmithKline Plc Argatroban Sales by Application in 2024
5.3.7 GlaxoSmithKline Plc Argatroban Sales by Geographic Area in 2024
5.3.8 GlaxoSmithKline Plc Recent Developments
5.4 fresenius-kabi
5.4.1 fresenius-kabi Company Information
5.4.2 fresenius-kabi Description, Business Overview
5.4.3 fresenius-kabi Argatroban Products Offered
5.4.4 fresenius-kabi Argatroban Sales, Revenue and Gross Margin (2020-2025)
5.4.5 fresenius-kabi Argatroban Sales by Product in 2024
5.4.6 fresenius-kabi Argatroban Sales by Application in 2024
5.4.7 fresenius-kabi Argatroban Sales by Geographic Area in 2024
5.4.8 fresenius-kabi Recent Developments
5.5 Eagle Pharmaceuticals, Inc
5.5.1 Eagle Pharmaceuticals, Inc Company Information
5.5.2 Eagle Pharmaceuticals, Inc Description, Business Overview
5.5.3 Eagle Pharmaceuticals, Inc Argatroban Products Offered
5.5.4 Eagle Pharmaceuticals, Inc Argatroban Sales, Revenue and Gross Margin (2020-2025)
5.5.5 Eagle Pharmaceuticals, Inc Argatroban Sales by Product in 2024
5.5.6 Eagle Pharmaceuticals, Inc Argatroban Sales by Application in 2024
5.5.7 Eagle Pharmaceuticals, Inc Argatroban Sales by Geographic Area in 2024
5.5.8 Eagle Pharmaceuticals, Inc Recent Developments
5.6 Mitsubishi Tanabe Pharma
5.6.1 Mitsubishi Tanabe Pharma Company Information
5.6.2 Mitsubishi Tanabe Pharma Description, Business Overview
5.6.3 Mitsubishi Tanabe Pharma Argatroban Products Offered
5.6.4 Mitsubishi Tanabe Pharma Argatroban Sales, Revenue and Gross Margin (2020-2025)
5.6.5 Mitsubishi Tanabe Pharma Argatroban Sales by Product in 2024
5.6.6 Mitsubishi Tanabe Pharma Argatroban Sales by Application in 2024
5.6.7 Mitsubishi Tanabe Pharma Argatroban Sales by Geographic Area in 2024
5.6.8 Mitsubishi Tanabe Pharma Recent Developments
5.7 Teva Pharmaceutical Industries Ltd
5.7.1 Teva Pharmaceutical Industries Ltd Company Information
5.7.2 Teva Pharmaceutical Industries Ltd Description, Business Overview
5.7.3 Teva Pharmaceutical Industries Ltd Argatroban Products Offered
5.7.4 Teva Pharmaceutical Industries Ltd Argatroban Sales, Revenue and Gross Margin (2020-2025)
5.7.5 Teva Pharmaceutical Industries Ltd Argatroban Sales by Product in 2024
5.7.6 Teva Pharmaceutical Industries Ltd Argatroban Sales by Application in 2024
5.7.7 Teva Pharmaceutical Industries Ltd Argatroban Sales by Geographic Area in 2024
5.7.8 Teva Pharmaceutical Industries Ltd Recent Developments
5.8 WEST-WARD,INC
5.8.1 WEST-WARD,INC Company Information
5.8.2 WEST-WARD,INC Description, Business Overview
5.8.3 WEST-WARD,INC Argatroban Products Offered
5.8.4 WEST-WARD,INC Argatroban Sales, Revenue and Gross Margin (2020-2025)
5.8.5 WEST-WARD,INC Argatroban Sales by Product in 2024
5.8.6 WEST-WARD,INC Argatroban Sales by Application in 2024
5.8.7 WEST-WARD,INC Argatroban Sales by Geographic Area in 2024
5.8.8 WEST-WARD,INC Recent Developments
6 North America
6.1 North America Argatroban Market Size YoY Growth 2020-2031
6.2 North America Argatroban Market Facts & Figures by Country
6.2.1 North America Argatroban Sales by Country (2020-2031)
6.2.2 North America Argatroban Revenue by Country (2020-2031)
6.3 North America Argatroban Sales by Type (2020-2025)
6.4 North America Argatroban Sales by Application (2020-2025)
7 Asia-Pacific
7.1 Asia-Pacific Argatroban Market Size YoY Growth 2020-2031
7.2 Asia-Pacific Argatroban Market Facts & Figures by Region
7.2.1 Asia-Pacific Argatroban Sales by Region (2020-2031)
7.2.2 Asia-Pacific Argatroban Revenue by Region (2020-2031)
7.3 Asia-Pacific Argatroban Sales by Type (2020-2025)
7.4 Asia-Pacific Argatroban Sales by Application (2020-2025)
8 Europe
8.1 Europe Argatroban Market Size YoY Growth 2020-2031
8.2 Europe Argatroban Market Facts & Figures by Country
8.2.1 Europe Argatroban Sales by Country (2020-2031)
8.2.2 Europe Argatroban Revenue by Country (2020-2031)
8.3 Europe Argatroban Sales by Type (2020-2025)
8.4 Europe Argatroban Sales by Application (2020-2025)
9 Latin America
9.1 Latin America Argatroban Market Size YoY Growth 2020-2031
9.2 Latin America Argatroban Market Facts & Figures by Country
9.2.1 Latin America Argatroban Sales by Country (2020-2031)
9.2.2 Latin America Argatroban Revenue by Country (2020-2031)
9.3 Latin America Argatroban Sales by Type (2020-2025)
9.4 Latin America Argatroban Sales by Application (2020-2025)
10 Middle East and Africa
10.1 Latin America Argatroban Market Size YoY Growth 2020-2031
10.2 Middle East and Africa Argatroban Market Facts & Figures by Country
10.2.1 Middle East and Africa Argatroban Sales by Country (2020-2031)
10.2.2 Middle East and Africa Argatroban Revenue by Country (2020-2031)
10.3 Middle East and Africa Argatroban Sales by Type (2020-2025)
10.4 Middle East and Africa Argatroban Sales by Application (2020-2025)
11 Supply Chain and Sales Channel analysis
11.1 Argatroban Supply Chain Analysis
11.2 Argatroban Key Raw Materials and Upstream Suppliers
11.3 Argatroban Clients Analysis
11.4 Argatroban Sales Channel and Sales Model Analysis
11.4.1 Argatroban Distribution Channel Analysis: Indirect Sales VS Direct Sales
11.4.2 Argatroban Distribution Channel Analysis: Online Sales VS Offline Sales
11.4.3 Argatroban Distributors
12 Argatroban Market Dynamics
12.1 Argatroban Industry Trends
12.2 Argatroban Market Drivers
12.3 Argatroban Market Challenges
12.4 Argatroban Market Restraints
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.1.1 Research Programs/Design
14.1.1.2 Market Size Estimation
14.1.1.3 Market Breakdown and Data Triangulation
14.1.2 Data Source
14.1.2.1 Secondary Sources
14.1.2.2 Primary Sources
14.2 Author Details
14.3 Disclaimer
List of Tables
Table 1. Global Argatroban Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Global Argatroban Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 3. Global Argatroban Market Size by Region (US$ Million): 2024 VS 2031
Table 4. Global Argatroban Sales by Region (2020-2025) & (g)
Table 5. Global Argatroban Sales Forecast by Region (2026-2031) & (g)
Table 6. Global Argatroban Revenue by Region (2020-2025) & (US$ Million)
Table 7. Global Argatroban Revenue Forecast by Region (2026-2031) & (US$ Million)
Table 8. Global Argatroban Sales Volume by Type (2020-2025) & (g)
Table 9. Global Argatroban Sales Volume by Type (2026-2031) & (g)
Table 10. Global Argatroban Revenue by Type (2020-2025) & (US$ Million)
Table 11. Global Argatroban Revenue Forecast by Type (2026-2031) & (US$ Million)
Table 12. Global Argatroban Sales Volume by Application (2020-2025) & (g)
Table 13. Global Argatroban Sales Volume by Application (2026-2031) & (g)
Table 14. Global Argatroban Revenue by Application (2020-2025) & (US$ Million)
Table 15. Global Argatroban Revenue by Application (2026-2031) & (US$ Million)
Table 16. Global Argatroban Sales by Manufacturer (2020-2025) & (g)
Table 17. Global Argatroban Sales Share by Manufacturer (2020-2025)
Table 18. Argatroban Revenue by Manufacturer (2020-2025) & (US$ Million)
Table 19. Argatroban Revenue Share by Manufacturer (2020-2025)
Table 20. Key Manufacturers Argatroban Price (2020-2025) & (USD/g)
Table 21. Ranking of Global Top Argatroban Manufacturers by Revenue (US$ Million) in 2024
Table 22. Global Argatroban Manufacturers Market Concentration Ratio (CR5 and HHI) & (2020-2025)
Table 23. Global Argatroban by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Argatroban as of 2024)
Table 24. Argatroban Manufacturers Manufacturing Base Distribution and Headquarters
Table 25. Date of International Manufacturers Enter into Argatroban Market
Table 26. Manufacturers Argatroban Product Type and Application
Table 27. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 28. Pfizer, Inc Company Information
Table 29. Pfizer, Inc Description and Business Overview
Table 30. Pfizer, Inc Argatroban Product
Table 31. Pfizer, Inc Argatroban Sales (g), Revenue (US$ Million), Price (USD/g) and Gross Margin (2020-2025)
Table 32. Pfizer, Inc Sales Proportion of Argatroban by Product in 2024
Table 33. Pfizer, Inc Sales Proportion of Argatroban by Application in 2024
Table 34. Pfizer, Inc Sales Proportion of Argatroban by Geographic Area in 2024
Table 35. Pfizer, Inc Recent Developments
Table 36. SANDOZ Company Information
Table 37. SANDOZ Description and Business Overview
Table 38. SANDOZ Argatroban Product
Table 39. SANDOZ Argatroban Sales (g), Revenue (US$ Million), Price (USD/g) and Gross Margin (2020-2025)
Table 40. SANDOZ Sales Proportion of Argatroban by Product in 2024
Table 41. SANDOZ Sales Proportion of Argatroban by Application in 2024
Table 42. SANDOZ Sales Proportion of Argatroban by Geographic Area in 2024
Table 43. SANDOZ Recent Developments
Table 44. GlaxoSmithKline Plc Company Information
Table 45. GlaxoSmithKline Plc Description and Business Overview
Table 46. GlaxoSmithKline Plc Argatroban Product
Table 47. GlaxoSmithKline Plc Argatroban Sales (g), Revenue (US$ Million), Price (USD/g) and Gross Margin (2020-2025)
Table 48. GlaxoSmithKline Plc Sales Proportion of Argatroban by Product in 2024
Table 49. GlaxoSmithKline Plc Sales Proportion of Argatroban by Application in 2024
Table 50. GlaxoSmithKline Plc Sales Proportion of Argatroban by Geographic Area in 2024
Table 51. GlaxoSmithKline Plc Recent Developments
Table 52. fresenius-kabi Company Information
Table 53. fresenius-kabi Description and Business Overview
Table 54. fresenius-kabi Argatroban Product
Table 55. fresenius-kabi Argatroban Sales (g), Revenue (US$ Million), Price (USD/g) and Gross Margin (2020-2025)
Table 56. fresenius-kabi Sales Proportion of Argatroban by Product in 2024
Table 57. fresenius-kabi Sales Proportion of Argatroban by Application in 2024
Table 58. fresenius-kabi Sales Proportion of Argatroban by Geographic Area in 2024
Table 59. fresenius-kabi Recent Developments
Table 60. Eagle Pharmaceuticals, Inc Company Information
Table 61. Eagle Pharmaceuticals, Inc Description and Business Overview
Table 62. Eagle Pharmaceuticals, Inc Argatroban Product
Table 63. Eagle Pharmaceuticals, Inc Argatroban Sales (g), Revenue (US$ Million), Price (USD/g) and Gross Margin (2020-2025)
Table 64. Eagle Pharmaceuticals, Inc Sales Proportion of Argatroban by Product in 2024
Table 65. Eagle Pharmaceuticals, Inc Sales Proportion of Argatroban by Application in 2024
Table 66. Eagle Pharmaceuticals, Inc Sales Proportion of Argatroban by Geographic Area in 2024
Table 67. Eagle Pharmaceuticals, Inc Recent Developments
Table 68. Mitsubishi Tanabe Pharma Company Information
Table 69. Mitsubishi Tanabe Pharma Description and Business Overview
Table 70. Mitsubishi Tanabe Pharma Argatroban Product
Table 71. Mitsubishi Tanabe Pharma Argatroban Sales (g), Revenue (US$ Million), Price (USD/g) and Gross Margin (2020-2025)
Table 72. Mitsubishi Tanabe Pharma Sales Proportion of Argatroban by Product in 2024
Table 73. Mitsubishi Tanabe Pharma Sales Proportion of Argatroban by Application in 2024
Table 74. Mitsubishi Tanabe Pharma Sales Proportion of Argatroban by Geographic Area in 2024
Table 75. Mitsubishi Tanabe Pharma Recent Developments
Table 76. Teva Pharmaceutical Industries Ltd Company Information
Table 77. Teva Pharmaceutical Industries Ltd Description and Business Overview
Table 78. Teva Pharmaceutical Industries Ltd Argatroban Product
Table 79. Teva Pharmaceutical Industries Ltd Argatroban Sales (g), Revenue (US$ Million), Price (USD/g) and Gross Margin (2020-2025)
Table 80. Teva Pharmaceutical Industries Ltd Sales Proportion of Argatroban by Product in 2024
Table 81. Teva Pharmaceutical Industries Ltd Sales Proportion of Argatroban by Application in 2024
Table 82. Teva Pharmaceutical Industries Ltd Sales Proportion of Argatroban by Geographic Area in 2024
Table 83. Teva Pharmaceutical Industries Ltd Recent Developments
Table 84. WEST-WARD,INC Company Information
Table 85. WEST-WARD,INC Description and Business Overview
Table 86. WEST-WARD,INC Argatroban Product
Table 87. WEST-WARD,INC Argatroban Sales (g), Revenue (US$ Million), Price (USD/g) and Gross Margin (2020-2025)
Table 88. WEST-WARD,INC Sales Proportion of Argatroban by Product in 2024
Table 89. WEST-WARD,INC Sales Proportion of Argatroban by Application in 2024
Table 90. WEST-WARD,INC Sales Proportion of Argatroban by Geographic Area in 2024
Table 91. WEST-WARD,INC Recent Developments
Table 92. North America Argatroban Sales by Country (2020-2025) & (g)
Table 93. North America Argatroban Sales by Country (2026-2031) & (g)
Table 94. North America Argatroban Revenue by Country (2020-2025) & (US$ Million)
Table 95. North America Argatroban Revenue by Country (2026-2031) & (US$ Million)
Table 96. North America Argatroban Sales by Type (2020-2025) & (g)
Table 97. North America Argatroban Sales by Application (2020-2025) & (g)
Table 98. Asia-Pacific Argatroban Sales by Region (2020-2025) & (g)
Table 99. Asia-Pacific Argatroban Sales by Region (2026-2031) & (g)
Table 100. Asia-Pacific Argatroban Revenue by Region (2020-2025) & (US$ Million)
Table 101. Asia-Pacific Argatroban Revenue by Region (2026-2031) & (US$ Million)
Table 102. Asia-Pacific Argatroban Sales by Type (2020-2025) & (g)
Table 103. Asia-Pacific Argatroban Sales by Application (2020-2025) & (g)
Table 104. Europe Argatroban Sales by Country (2020-2025) & (g)
Table 105. Europe Argatroban Sales by Country (2026-2031) & (g)
Table 106. Europe Argatroban Revenue by Country (2020-2025) & (US$ Million)
Table 107. Europe Argatroban Revenue by Country (2026-2031) & (US$ Million)
Table 108. Europe Argatroban Sales by Type (2020-2025) & (g)
Table 109. Europe Argatroban Sales by Application (2020-2025) & (g)
Table 110. Latin America Argatroban Sales by Country (2020-2025) & (g)
Table 111. Latin America Argatroban Sales by Country (2026-2031) & (g)
Table 112. Latin America Argatroban Revenue by Country (2020-2025) & (US$ Million)
Table 113. Latin America Argatroban Revenue by Country (2026-2031) & (US$ Million)
Table 114. Latin America Argatroban Sales by Type (2020-2025) & (g)
Table 115. Latin America Argatroban Sales by Application (2020-2025) & (g)
Table 116. Middle East and Africa Argatroban Sales by Country (2020-2025) & (g)
Table 117. Middle East and Africa Argatroban Sales by Country (2026-2031) & (g)
Table 118. Middle East and Africa Argatroban Revenue by Country (2020-2025) & (US$ Million)
Table 119. Middle East and Africa Argatroban Revenue by Country (2026-2031) & (US$ Million)
Table 120. Middle East and Africa Argatroban Sales by Type (2020-2025) & (g)
Table 121. Middle East and Africa Argatroban Sales by Application (2020-2025) & (g)
Table 122. Argatroban Key Raw Materials, Industry Status and Trend
Table 123. Argatroban Key Raw Materials and Upstream Suppliers
Table 124. Argatroban Clients Status and Trend
Table 125. Argatroban Typical Clients
Table 126. Argatroban Distributors
Table 127. Argatroban Market Trends
Table 128. Argatroban Market Drivers
Table 129. Argatroban Market Challenges
Table 130. Argatroban Market Restraints
Table 131. Research Programs/Design for This Report
Table 132. Key Data Information from Secondary Sources
Table 133. Key Data Information from Primary Sources
Table 134. QYR Business Unit and Senior & Team Lead Analysts
List of Figures
Figure 1. Argatroban Product Picture
Figure 2. Global Argatroban Market Size by Type (US$ Million): 2020 VS 2024 VS 2031
Figure 3. Global Argatroban Sales Market Share by Type in 2024 & 2031
Figure 4. Argatroban Powder Product Picture
Figure 5. Argatroban Injection Product Picture
Figure 6. Global Argatroban Market Size by Application (US$ Million): 2020 VS 2024 VS 2031
Figure 7. Global Argatroban Sales Market Share by Application in 2024 & 2031
Figure 8. Heparin-induced Thrombocytopenia (HIT)
Figure 9. Percutaneous Coronary Intervention
Figure 10. Cerebral Arterial Thrombosis
Figure 11. Argatroban Report Years Considered
Figure 12. Global Argatroban Revenue, (US$ Million), 2020 VS 2024 VS 2031
Figure 13. Global Argatroban Market Size 2020-2031 (US$ Million)
Figure 14. Global Argatroban Sales 2020-2031 (g)
Figure 15. Global Argatroban Sales Market Share Forecast by Region (2020-2031)
Figure 16. Global Argatroban Revenue Market Share by Region (2020-2031)
Figure 17. Global Argatroban Sales Market Share Forecast by Type (2020-2031)
Figure 18. Global Argatroban Revenue Market Share Forecast by Type (2020-2031)
Figure 19. Argatroban Average Selling Price (ASP) by Type (2020-2025) & (USD/g)
Figure 20. Global Argatroban Sales Market Share Forecast by Application (2020-2031)
Figure 21. Global Argatroban Revenue Market Share Forecast by Application (2020-2031)
Figure 22. Argatroban Average Selling Price (ASP) by Application (2020-2025) & (USD/g)
Figure 23. Argatroban Powder of Argatroban Revenue Market Share by Application, 2024 VS 2031
Figure 24. Argatroban Injection of Argatroban Revenue Market Share by Application, 2024 VS 2031
Figure 25. Global Argatroban Sales Share by Manufacturer in 2024
Figure 26. Argatroban Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
Figure 27. Argatroban Powder Market Sales Proportion by Manufacturer in 2024
Figure 28. Argatroban Injection Market Sales Proportion by Manufacturer in 2024
Figure 29. North America Argatroban Revenue 2020-2031 (US$ Million)
Figure 30. North America Argatroban Sales Market Share by Type (2020-2025)
Figure 31. North America Argatroban Sales Market Share by Application (2020-2025)
Figure 32. Asia-Pacific Argatroban Revenue 2020-2031 (US$ Million)
Figure 33. Asia-Pacific Argatroban Sales Market Share by Region (2020-2031)
Figure 34. Asia-Pacific Argatroban Revenue Market Share by Region (2020-2031)
Figure 35. Asia-Pacific Argatroban Sales Market Share by Type (2020-2025)
Figure 36. Asia-Pacific Argatroban Sales Market Share by Application (2020-2025)
Figure 37. Europe Argatroban Revenue Growth Rate 2020-2031 (US$ Million)
Figure 38. Europe Argatroban Sales Market Share by Country (2020-2031)
Figure 39. Europe Argatroban Revenue Market Share by Country (2020-2031)
Figure 40. Europe Argatroban Sales Market Share by Type (2020-2025)
Figure 41. Europe Argatroban Sales Market Share by Application (2020-2025)
Figure 42. Latin America Argatroban Revenue Growth Rate 2020-2031 (US$ Million)
Figure 43. Latin America Argatroban Sales Market Share by Country (2020-2031)
Figure 44. Latin America Argatroban Revenue Market Share by Country (2020-2025)
Figure 45. Latin America Argatroban Sales Market Share by Type (2020-2025)
Figure 46. Latin America Argatroban Sales Market Share by Application (2020-2025)
Figure 47. Middle East and Africa Argatroban Revenue Growth Rate 2020-2031 (US$ Million)
Figure 48. Middle East and Africa Argatroban Sales Market Share by Country (2020-2031)
Figure 49. Middle East and Africa Argatroban Revenue Market Share by Country (2020-2031)
Figure 50. Middle East and Africa Argatroban Sales Market Share by Type (2020-2025)
Figure 51. Middle East and Africa Argatroban Sales Market Share by Application (2020-2025)
Figure 52. Argatroban Supply Chain (Upstream and Downstream Market)
Figure 53. Global Production Market Share of Argatroban Raw Materials by Region in 2024
Figure 54. Argatroban Distribution Channels
Figure 55. Global Argatroban Percentage 2020-2031: Indirect Sales VS Direct Sales
Figure 56. Global Argatroban Percentage 2020-2031: Online Sales VS Offline Sales
Figure 57. Bottom-up and Top-down Approaches for This Report
Figure 58. Data Triangulation
Figure 59. Key Executives Interviewed
Table 1. Global Argatroban Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Global Argatroban Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 3. Global Argatroban Market Size by Region (US$ Million): 2024 VS 2031
Table 4. Global Argatroban Sales by Region (2020-2025) & (g)
Table 5. Global Argatroban Sales Forecast by Region (2026-2031) & (g)
Table 6. Global Argatroban Revenue by Region (2020-2025) & (US$ Million)
Table 7. Global Argatroban Revenue Forecast by Region (2026-2031) & (US$ Million)
Table 8. Global Argatroban Sales Volume by Type (2020-2025) & (g)
Table 9. Global Argatroban Sales Volume by Type (2026-2031) & (g)
Table 10. Global Argatroban Revenue by Type (2020-2025) & (US$ Million)
Table 11. Global Argatroban Revenue Forecast by Type (2026-2031) & (US$ Million)
Table 12. Global Argatroban Sales Volume by Application (2020-2025) & (g)
Table 13. Global Argatroban Sales Volume by Application (2026-2031) & (g)
Table 14. Global Argatroban Revenue by Application (2020-2025) & (US$ Million)
Table 15. Global Argatroban Revenue by Application (2026-2031) & (US$ Million)
Table 16. Global Argatroban Sales by Manufacturer (2020-2025) & (g)
Table 17. Global Argatroban Sales Share by Manufacturer (2020-2025)
Table 18. Argatroban Revenue by Manufacturer (2020-2025) & (US$ Million)
Table 19. Argatroban Revenue Share by Manufacturer (2020-2025)
Table 20. Key Manufacturers Argatroban Price (2020-2025) & (USD/g)
Table 21. Ranking of Global Top Argatroban Manufacturers by Revenue (US$ Million) in 2024
Table 22. Global Argatroban Manufacturers Market Concentration Ratio (CR5 and HHI) & (2020-2025)
Table 23. Global Argatroban by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Argatroban as of 2024)
Table 24. Argatroban Manufacturers Manufacturing Base Distribution and Headquarters
Table 25. Date of International Manufacturers Enter into Argatroban Market
Table 26. Manufacturers Argatroban Product Type and Application
Table 27. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 28. Pfizer, Inc Company Information
Table 29. Pfizer, Inc Description and Business Overview
Table 30. Pfizer, Inc Argatroban Product
Table 31. Pfizer, Inc Argatroban Sales (g), Revenue (US$ Million), Price (USD/g) and Gross Margin (2020-2025)
Table 32. Pfizer, Inc Sales Proportion of Argatroban by Product in 2024
Table 33. Pfizer, Inc Sales Proportion of Argatroban by Application in 2024
Table 34. Pfizer, Inc Sales Proportion of Argatroban by Geographic Area in 2024
Table 35. Pfizer, Inc Recent Developments
Table 36. SANDOZ Company Information
Table 37. SANDOZ Description and Business Overview
Table 38. SANDOZ Argatroban Product
Table 39. SANDOZ Argatroban Sales (g), Revenue (US$ Million), Price (USD/g) and Gross Margin (2020-2025)
Table 40. SANDOZ Sales Proportion of Argatroban by Product in 2024
Table 41. SANDOZ Sales Proportion of Argatroban by Application in 2024
Table 42. SANDOZ Sales Proportion of Argatroban by Geographic Area in 2024
Table 43. SANDOZ Recent Developments
Table 44. GlaxoSmithKline Plc Company Information
Table 45. GlaxoSmithKline Plc Description and Business Overview
Table 46. GlaxoSmithKline Plc Argatroban Product
Table 47. GlaxoSmithKline Plc Argatroban Sales (g), Revenue (US$ Million), Price (USD/g) and Gross Margin (2020-2025)
Table 48. GlaxoSmithKline Plc Sales Proportion of Argatroban by Product in 2024
Table 49. GlaxoSmithKline Plc Sales Proportion of Argatroban by Application in 2024
Table 50. GlaxoSmithKline Plc Sales Proportion of Argatroban by Geographic Area in 2024
Table 51. GlaxoSmithKline Plc Recent Developments
Table 52. fresenius-kabi Company Information
Table 53. fresenius-kabi Description and Business Overview
Table 54. fresenius-kabi Argatroban Product
Table 55. fresenius-kabi Argatroban Sales (g), Revenue (US$ Million), Price (USD/g) and Gross Margin (2020-2025)
Table 56. fresenius-kabi Sales Proportion of Argatroban by Product in 2024
Table 57. fresenius-kabi Sales Proportion of Argatroban by Application in 2024
Table 58. fresenius-kabi Sales Proportion of Argatroban by Geographic Area in 2024
Table 59. fresenius-kabi Recent Developments
Table 60. Eagle Pharmaceuticals, Inc Company Information
Table 61. Eagle Pharmaceuticals, Inc Description and Business Overview
Table 62. Eagle Pharmaceuticals, Inc Argatroban Product
Table 63. Eagle Pharmaceuticals, Inc Argatroban Sales (g), Revenue (US$ Million), Price (USD/g) and Gross Margin (2020-2025)
Table 64. Eagle Pharmaceuticals, Inc Sales Proportion of Argatroban by Product in 2024
Table 65. Eagle Pharmaceuticals, Inc Sales Proportion of Argatroban by Application in 2024
Table 66. Eagle Pharmaceuticals, Inc Sales Proportion of Argatroban by Geographic Area in 2024
Table 67. Eagle Pharmaceuticals, Inc Recent Developments
Table 68. Mitsubishi Tanabe Pharma Company Information
Table 69. Mitsubishi Tanabe Pharma Description and Business Overview
Table 70. Mitsubishi Tanabe Pharma Argatroban Product
Table 71. Mitsubishi Tanabe Pharma Argatroban Sales (g), Revenue (US$ Million), Price (USD/g) and Gross Margin (2020-2025)
Table 72. Mitsubishi Tanabe Pharma Sales Proportion of Argatroban by Product in 2024
Table 73. Mitsubishi Tanabe Pharma Sales Proportion of Argatroban by Application in 2024
Table 74. Mitsubishi Tanabe Pharma Sales Proportion of Argatroban by Geographic Area in 2024
Table 75. Mitsubishi Tanabe Pharma Recent Developments
Table 76. Teva Pharmaceutical Industries Ltd Company Information
Table 77. Teva Pharmaceutical Industries Ltd Description and Business Overview
Table 78. Teva Pharmaceutical Industries Ltd Argatroban Product
Table 79. Teva Pharmaceutical Industries Ltd Argatroban Sales (g), Revenue (US$ Million), Price (USD/g) and Gross Margin (2020-2025)
Table 80. Teva Pharmaceutical Industries Ltd Sales Proportion of Argatroban by Product in 2024
Table 81. Teva Pharmaceutical Industries Ltd Sales Proportion of Argatroban by Application in 2024
Table 82. Teva Pharmaceutical Industries Ltd Sales Proportion of Argatroban by Geographic Area in 2024
Table 83. Teva Pharmaceutical Industries Ltd Recent Developments
Table 84. WEST-WARD,INC Company Information
Table 85. WEST-WARD,INC Description and Business Overview
Table 86. WEST-WARD,INC Argatroban Product
Table 87. WEST-WARD,INC Argatroban Sales (g), Revenue (US$ Million), Price (USD/g) and Gross Margin (2020-2025)
Table 88. WEST-WARD,INC Sales Proportion of Argatroban by Product in 2024
Table 89. WEST-WARD,INC Sales Proportion of Argatroban by Application in 2024
Table 90. WEST-WARD,INC Sales Proportion of Argatroban by Geographic Area in 2024
Table 91. WEST-WARD,INC Recent Developments
Table 92. North America Argatroban Sales by Country (2020-2025) & (g)
Table 93. North America Argatroban Sales by Country (2026-2031) & (g)
Table 94. North America Argatroban Revenue by Country (2020-2025) & (US$ Million)
Table 95. North America Argatroban Revenue by Country (2026-2031) & (US$ Million)
Table 96. North America Argatroban Sales by Type (2020-2025) & (g)
Table 97. North America Argatroban Sales by Application (2020-2025) & (g)
Table 98. Asia-Pacific Argatroban Sales by Region (2020-2025) & (g)
Table 99. Asia-Pacific Argatroban Sales by Region (2026-2031) & (g)
Table 100. Asia-Pacific Argatroban Revenue by Region (2020-2025) & (US$ Million)
Table 101. Asia-Pacific Argatroban Revenue by Region (2026-2031) & (US$ Million)
Table 102. Asia-Pacific Argatroban Sales by Type (2020-2025) & (g)
Table 103. Asia-Pacific Argatroban Sales by Application (2020-2025) & (g)
Table 104. Europe Argatroban Sales by Country (2020-2025) & (g)
Table 105. Europe Argatroban Sales by Country (2026-2031) & (g)
Table 106. Europe Argatroban Revenue by Country (2020-2025) & (US$ Million)
Table 107. Europe Argatroban Revenue by Country (2026-2031) & (US$ Million)
Table 108. Europe Argatroban Sales by Type (2020-2025) & (g)
Table 109. Europe Argatroban Sales by Application (2020-2025) & (g)
Table 110. Latin America Argatroban Sales by Country (2020-2025) & (g)
Table 111. Latin America Argatroban Sales by Country (2026-2031) & (g)
Table 112. Latin America Argatroban Revenue by Country (2020-2025) & (US$ Million)
Table 113. Latin America Argatroban Revenue by Country (2026-2031) & (US$ Million)
Table 114. Latin America Argatroban Sales by Type (2020-2025) & (g)
Table 115. Latin America Argatroban Sales by Application (2020-2025) & (g)
Table 116. Middle East and Africa Argatroban Sales by Country (2020-2025) & (g)
Table 117. Middle East and Africa Argatroban Sales by Country (2026-2031) & (g)
Table 118. Middle East and Africa Argatroban Revenue by Country (2020-2025) & (US$ Million)
Table 119. Middle East and Africa Argatroban Revenue by Country (2026-2031) & (US$ Million)
Table 120. Middle East and Africa Argatroban Sales by Type (2020-2025) & (g)
Table 121. Middle East and Africa Argatroban Sales by Application (2020-2025) & (g)
Table 122. Argatroban Key Raw Materials, Industry Status and Trend
Table 123. Argatroban Key Raw Materials and Upstream Suppliers
Table 124. Argatroban Clients Status and Trend
Table 125. Argatroban Typical Clients
Table 126. Argatroban Distributors
Table 127. Argatroban Market Trends
Table 128. Argatroban Market Drivers
Table 129. Argatroban Market Challenges
Table 130. Argatroban Market Restraints
Table 131. Research Programs/Design for This Report
Table 132. Key Data Information from Secondary Sources
Table 133. Key Data Information from Primary Sources
Table 134. QYR Business Unit and Senior & Team Lead Analysts
List of Figures
Figure 1. Argatroban Product Picture
Figure 2. Global Argatroban Market Size by Type (US$ Million): 2020 VS 2024 VS 2031
Figure 3. Global Argatroban Sales Market Share by Type in 2024 & 2031
Figure 4. Argatroban Powder Product Picture
Figure 5. Argatroban Injection Product Picture
Figure 6. Global Argatroban Market Size by Application (US$ Million): 2020 VS 2024 VS 2031
Figure 7. Global Argatroban Sales Market Share by Application in 2024 & 2031
Figure 8. Heparin-induced Thrombocytopenia (HIT)
Figure 9. Percutaneous Coronary Intervention
Figure 10. Cerebral Arterial Thrombosis
Figure 11. Argatroban Report Years Considered
Figure 12. Global Argatroban Revenue, (US$ Million), 2020 VS 2024 VS 2031
Figure 13. Global Argatroban Market Size 2020-2031 (US$ Million)
Figure 14. Global Argatroban Sales 2020-2031 (g)
Figure 15. Global Argatroban Sales Market Share Forecast by Region (2020-2031)
Figure 16. Global Argatroban Revenue Market Share by Region (2020-2031)
Figure 17. Global Argatroban Sales Market Share Forecast by Type (2020-2031)
Figure 18. Global Argatroban Revenue Market Share Forecast by Type (2020-2031)
Figure 19. Argatroban Average Selling Price (ASP) by Type (2020-2025) & (USD/g)
Figure 20. Global Argatroban Sales Market Share Forecast by Application (2020-2031)
Figure 21. Global Argatroban Revenue Market Share Forecast by Application (2020-2031)
Figure 22. Argatroban Average Selling Price (ASP) by Application (2020-2025) & (USD/g)
Figure 23. Argatroban Powder of Argatroban Revenue Market Share by Application, 2024 VS 2031
Figure 24. Argatroban Injection of Argatroban Revenue Market Share by Application, 2024 VS 2031
Figure 25. Global Argatroban Sales Share by Manufacturer in 2024
Figure 26. Argatroban Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
Figure 27. Argatroban Powder Market Sales Proportion by Manufacturer in 2024
Figure 28. Argatroban Injection Market Sales Proportion by Manufacturer in 2024
Figure 29. North America Argatroban Revenue 2020-2031 (US$ Million)
Figure 30. North America Argatroban Sales Market Share by Type (2020-2025)
Figure 31. North America Argatroban Sales Market Share by Application (2020-2025)
Figure 32. Asia-Pacific Argatroban Revenue 2020-2031 (US$ Million)
Figure 33. Asia-Pacific Argatroban Sales Market Share by Region (2020-2031)
Figure 34. Asia-Pacific Argatroban Revenue Market Share by Region (2020-2031)
Figure 35. Asia-Pacific Argatroban Sales Market Share by Type (2020-2025)
Figure 36. Asia-Pacific Argatroban Sales Market Share by Application (2020-2025)
Figure 37. Europe Argatroban Revenue Growth Rate 2020-2031 (US$ Million)
Figure 38. Europe Argatroban Sales Market Share by Country (2020-2031)
Figure 39. Europe Argatroban Revenue Market Share by Country (2020-2031)
Figure 40. Europe Argatroban Sales Market Share by Type (2020-2025)
Figure 41. Europe Argatroban Sales Market Share by Application (2020-2025)
Figure 42. Latin America Argatroban Revenue Growth Rate 2020-2031 (US$ Million)
Figure 43. Latin America Argatroban Sales Market Share by Country (2020-2031)
Figure 44. Latin America Argatroban Revenue Market Share by Country (2020-2025)
Figure 45. Latin America Argatroban Sales Market Share by Type (2020-2025)
Figure 46. Latin America Argatroban Sales Market Share by Application (2020-2025)
Figure 47. Middle East and Africa Argatroban Revenue Growth Rate 2020-2031 (US$ Million)
Figure 48. Middle East and Africa Argatroban Sales Market Share by Country (2020-2031)
Figure 49. Middle East and Africa Argatroban Revenue Market Share by Country (2020-2031)
Figure 50. Middle East and Africa Argatroban Sales Market Share by Type (2020-2025)
Figure 51. Middle East and Africa Argatroban Sales Market Share by Application (2020-2025)
Figure 52. Argatroban Supply Chain (Upstream and Downstream Market)
Figure 53. Global Production Market Share of Argatroban Raw Materials by Region in 2024
Figure 54. Argatroban Distribution Channels
Figure 55. Global Argatroban Percentage 2020-2031: Indirect Sales VS Direct Sales
Figure 56. Global Argatroban Percentage 2020-2031: Online Sales VS Offline Sales
Figure 57. Bottom-up and Top-down Approaches for This Report
Figure 58. Data Triangulation
Figure 59. Key Executives Interviewed
Our team would be happy to assist you with your queries.
About us
Accurate data, The latest market trends, And deeper research directions.
Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals
Latest reports
Global Trichosanthes Kirilowii Extract Market Research Report 2026
Feb 24, 26
Global Glass Lined Containers Market Research Report 2026
Feb 24, 26
Global Open End Wrenches Market Research Report 2026
Feb 24, 26
Useful links
Our Contacts
Room 2306, T6 Fuxing World Financial Center, Kaifu District, Changsha, Hunan, China
(+86) 159 1069 5232